Source: UNIVERSITY OF MISSOURI submitted to NRP
ANTAGONISM OF OXIDATIVE STRESS INDUCED BY AFLATOXIN B1 IN WEANLING SWINE BY CURCUMINOIDS, THE PLANT POLYPHENOLS IN TURMERIC (CURCUMA LONGA)
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
0216532
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Oct 1, 2008
Project End Date
Sep 30, 2009
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
UNIVERSITY OF MISSOURI
(N/A)
COLUMBIA,MO 65211
Performing Department
V Biomedical Sciences
Non Technical Summary
Aflatoxin and other fungal toxins cause liver damage and other performance deficit in pigs. There is evidence in chickens that the chemical compounds in turmeric called curcuminoids can protect the birds from the effects of the toxin.
Animal Health Component
40%
Research Effort Categories
Basic
30%
Applied
40%
Developmental
30%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
3143510101030%
3143510104040%
3143510115030%
Goals / Objectives
The primary objective is to test the hypothesis that the antioxidant curcumin will have a protective effect against the effects of the mycotoxin, Aflatoxin B (AFB1). Specific aims are to 1) reproduce the effects of the toxin in one of the target species, i.e., swine; 2) characterize the changes in liver gene expression induced by the toxin; 3) demonstrate protective effects of the antioxidant against aflatoxicoses in swine as evidenced by improved performance and prevention of toxic effects; and 4) establish the genetic basis for animal susceptibility to the toxicant and for the antioxidant protection by identifying the toxin-affected gene pathways (oxidative stress, etc.) normalized byt he antioxidant.
Project Methods
Weanling swine will be fed a diet containing 0.5 ppm of Aflatoxin B1 with or without 220 ppm of curcumin for 21 days. Before feeding and at the end of the experiment, blood samples will be collected to assess the effect of the toxin on clinical chemistry, enzyme profiles and generation of oxidative stress. Animals will be observed for performance and adverse health effects. They will be sacrificed at the end of the experiment to examine the liver for alterations of oxidative/antioxidant pathway gene expression and enzyme activity as well as histopathological alterations indicative of tissue damage. The effect of curcumin in reversing the toxic effects of AFB1 will be assessed by a reversal of the above parameters.

Progress 10/01/08 to 09/30/09

Outputs
OUTPUTS: The proposed animal experiments have been completed. The effect of aflatoxin B1 (AFB1) and turmeric (TCMN) on growth parameters, clinical and histopathological parameters have been evaluated as presented below. Additional analyses including anti-oxidant gene expression and measurement of antioxidant activity parameters are currently being measured. PARTICIPANTS: Not relevant to this project. TARGET AUDIENCES: Not relevant to this project. PROJECT MODIFICATIONS: Not relevant to this project.

Impacts
Aflatoxins (AF) are contaminants of feed ingredients used in livestock rations and in human food and are produced by the fungi Aspergillus parasiticus and A. flavus. Aflatoxin B1 (AFB1), the most potent among the AFs, has been shown to cause feed refusal, decreased feed efficiency, impaired reproduction, immune suppression, jaundice, and hepatitis/cirrhosis of the liver in pigs (Newberne, 1973; Robens and Richard, 1992). AFB1 also increases free radical production, leading to oxidative damage and lipid peroxidation which might ultimately lead to cell damage and death (Surai, 2002). The yellowish pigments of turmeric (Curcuma longa) powder (TMP), referred to as total curcuminoids (TCMN) have been shown to have antioxidant properties (Soni et al., 1997) and to inhibit biotransformation of the AFs to their epoxide derivatives (Lee et al., 2001). The antioxidant properties of TCMN suggest that they may be able to prevent or reduce the toxic effects of aflatoxins (Galvano et al., 2001). Aim: To determine if curcuminoids from turmeric would prevent or reduce the toxic effects of AFB1 in weanling pigs fed dietary treatments for 21 days. Results and Discussion: Feed intake (FI) and body weight gain (BWG) were reduced (P less than 0.05) by AFB1 but were not affected (P greater than 0.05) by TCMN. No AFB1 by TCMN interactions (P greater than 0.05) were observed for FI or BWG. There was, however, a significant AFB1 by TCMN interaction (P less than 0.05) observed for feed efficiency (G:F). TCMN decreased G:F in pigs fed no AFB1, had no effect in pigs fed 0.5 mg AFB1/kg diet, but increased G:F in pigs fed 1 mg AFB1/kg diet. Relative kidney weights were not affected (P greater than 0.05) by dietary treatments. In contrast, relative liver weights increased (P less than 0.05) in pigs fed AFB1 and in pigs fed TCMN. No AFB1 by TCMN interactions (P greater than 0.05) were observed for relative kidney or relative liver weight. Serum concentrations of urinary nitrogen, creatinine, Na, K, Ca, P, Mg, albumen, globulin, total protein, GGT and CPK were not affected (P greater than 0.05) by dietary treatments. Serum AST was increased in pigs fed AF (P less than 0.05), as compared with controls, but was not affected (P greater than 0.05) by TCMN. There appeared to be a subtle increase in hepatocyte vacuolation associated with AF exposure. Results of this study are in contrast to previous study with broilers (Gowda et al., 2009) in which TCMN reduced the negative effects of AFB1 on broiler performance, serum chemistries, and liver weight. Possible explanations for the contrasting results may include species differences and the concentration of TCMN used in the current study (220 mg/kg diet), which was selected based on its efficacy in broilers. Major Findings: Dietary concentrations of AF as low as 0.5 mg/kg diet depressed growth performance of weanling pigs. TCMN from turmeric at 220 mg/kg diet was only marginally effective in preventing or reducing the toxic effects of AFB1.

Publications

  • No publications reported this period